History

Human beings have utilized plants and fungi to alter consciousness, seek spiritual and physical transformation, and heal both mental and physical ailments for millennia.

In the 1950s, scientists began investigating how these natural substances might address modern challenges and mental health needs. Despite promising research about the efficacy of these psychedelic compounds for the treatment of a myriad of problems – from depression, to alcoholism, to anxiety disorders and relationship issues – Congress criminalized the use of many naturally occurring psychoactive plants and fungi in 1970, halting all further research.  This was a tragic turn of events and was no doubt a reaction to the perceived threat of the 1960s counter-culture movement. Since this era, the use of these substances in the United States has largely gone underground.

Following a 50-year federal ban on research into the medical and health benefits of psychedelics, scientists recently resumed the investigation of these ancient medicines, exploring the therapeutic potential of psychedelic-assisted treatments in contemporary society. 

We are in 2024 witnessing a “psychedelic renaissance” in modern western culture.  Encouraging studies on treating substance use disorders, end-of-life anxiety, treatment-resistant depression and post-traumatic stress disorder are kindling a bright interest in psychoactive plants, fungi, and their synthetic counterparts.  Participants in these trials report not only objective improvements by scientific standards but also describe life-altering experiences in profound religious and spiritual terms.  These accounts have also revived interest in using psychedelics for religious practices, spiritual development and contemplative exercise.

Psilocybin is of particular interest to the field because it is naturally occurring, virtually harmless to the body, and inexpensive to produce.  Additionally, it is plentiful and found all over the globe.  Recently the FDA fast tracked the research around psilocybin due to such promising results in the treatment of depression and post-traumatic stress disorder.

Empowered by the legalization of psilocybin assisted therapy in Oregon and Colorado and supported by the licensing structure of the state Health Authorities, we stand at the precipice of a new frontier for healing in the western world.